You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

February 11, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

First-line stroke treatment may be given by paramedics

It is possible to get treatments to stroke patients even before they arrive at a hospital, according to a study published in the New England Journal of Medicine. » More on the benefits of early administration of magnesium sulfate

FDA approves Lucentis for treatment of diabetic retinopathy in people with DME

FDA has expanded the approved use of ranibizumab (Lucentis, Genentech) to treat diabetic retinopathy in patients with diabetic macular edema (DME). » More on diabetic retinopathy

Continuing Education

New and emerging therapies for the treatment of diabetes

This month and next month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss new and emerging medications for the treatment of diabetes.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT15-WKX27.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Study: Too many heart failure patients are treated with IV fluids

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, according to a Yale-led study, published in the Journal of the American College of Cardiology: Heart Failure. » Details

 

RELATED ARTICLES

Post-stroke drug combo linked to lower risk of stroke recurrence

FDA approves drug for ocular allergy itch relief

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group